A beta amyloid, cognition, and APOE genotype in healthy older adults
Yen Ying Lim, Kathryn A Ellis, David Ames, David Darby, Karra Harrington, Ralph N Martins, Colin L Masters, Christopher Rowe, Greg Savage, Cassandra Szoeke, Victor L Villemagne, Paul Maruff
Alzheimer's & Dementia | WILEY | Published : 2013
This investigation was funded in part by the study partners (Australian Commonwealth Scientific Industrial and Research Organization [CSIRO], Edith Cowan University [ECU], Mental Health Research Institute [MHRI], Alzheimer's Australia [AA], National Ageing Research Institute [NARI], Austin Health, CogState, Ltd., Hollywood Private Hospital, and Sir Charles Gardner Hospital). The AIBL investigators thank Richard Head (CSIRO) for initiating and facilitating the AIBL collaboration. The study also received support from the National Health and Medical Research Council (NHMRC) and the Dementia Collaborative Research Centres Program (DCRC2), as well as ongoing funding from the Science and Industry Endowment Fund (SIEF). C.S. was partially supported by research fellowships funded by AA and the NHMRC. AA (of Victoria and Western Australia) assisted with promotion of the study an screening of telephone calls from volunteers. The AIBL team thanks the clinicians who referred the AD patients to the study, including Associate Professor Brian Chambers, Professor Edmond Chiu, Dr. Roger Clarnette, Dr. Mary Davison, Dr. John Drago, Dr. Peter Drysdale, Dr. Jacqueline Gilbert, Dr. Kwang Lim, Professor Nicola Lautenschlager, Dr. Dina LoGiudice, Dr. Peter McCardle, Dr. Steve McFarlane, Dr. Alastair Mander, Dr. John Merory, Professor Daniel O'Connor, Dr. Ron Scholes, Dr. Mathew Samuel, Dr. Darshan Trivedi, and Associate Professor Michael Woodward. We thank all those who participated in the study for their commitment and dedication to helping advance research into the early detection and cause of AD.